Several novel solutions are now accessible in the Britain for controlling glucose intolerance. copyright , Januvia , and Trulicity represent distinct approaches, with Saxenda and Mounjaro being injectable peptide receptor activators primarily aimed at slimming alongside glucose control , while Me